Rui Cao

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Positron Emission Tomography

Epidermal Growth Factor Receptor

Fluorescence Imaging

Top Venues

Molecular pharmaceutics

Journal of medicinal chemistry

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Li, Rui Cao, Kaixin Chen, Chunrong Qu, Kun Qian, Jia Lin, Renda Li, Chaoquan Lai, Xiao Wang, Zijian Han, Zhijian Xu, Liping Zhou, Shaoli Song, Jianming Zhu, Zhen Cheng
Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold. Bioconjugate chemistry (2024)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular pharmaceutics 20 (2) (2023)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Correction to "Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor". Molecular pharmaceutics (2023)
Chaoquan Lai, Rui Cao, Renda Li, Chunfeng He, Xiao Wang, Hui Shi, Chunrong Qu, Kun Qian, Shaoli Song, Wen-Hua Chen, Zhen Cheng
Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma. Molecular pharmaceutics (2023)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular pharmaceutics 20 (2) (2023)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular pharmaceutics 20 (2) (2023)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular pharmaceutics 20 (2) (2023)
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular pharmaceutics (2023)
Rui Cao, Renda Li, Chaoquan Lai, Hui Shi, Hongguang Liu, Zhen Cheng
Development of a Novel HER2-Targeted Peptide Probe for Dual-Modal Imaging of Tumors. Journal of medicinal chemistry (2023)